KOICHI TAKAHASHI to Hematopoietic Stem Cells
This is a "connection" page, showing publications KOICHI TAKAHASHI has written about Hematopoietic Stem Cells.
Connection Strength
0.493
-
Clonal evolution and hierarchy in myeloid malignancies. Trends Cancer. 2023 09; 9(9):707-715.
Score: 0.135
-
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. Blood. 2022 10 20; 140(16):1753-1763.
Score: 0.130
-
Nrf2 regulates haematopoietic stem cell function. Nat Cell Biol. 2013 Mar; 15(3):309-16.
Score: 0.066
-
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia. Cell Rep Med. 2024 Jun 18; 5(6):101585.
Score: 0.036
-
Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration. Nat Commun. 2024 Jan 15; 15(1):538.
Score: 0.035
-
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells. Nat Cell Biol. 2023 04; 25(4):528-539.
Score: 0.033
-
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. Nat Med. 2022 03; 28(3):557-567.
Score: 0.031
-
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1. Blood. 2019 07 04; 134(1):59-73.
Score: 0.025